| Survivors (n= 37) | Nonsurvivors (n= 24) | P value |
---|---|---|---|
Characteristics | Â | Â | Â |
   Age, years | 68 (49-76) | 74 (61-82) | 0.167 |
   Male, n (%) | 18 (49) | 15 (63) | 0.289 |
   BMI, kg/m2 | 23 (21-25) | 23 (20-26) | 0.732 |
   APACHE IV score | 79 (66-94) | 93 (69-99) | 0.339 |
   APACHE IV predicted mortality, % | 28 (17-53) | 48 (35-61) | 0.039 |
   SOFA score | 10 (8-12) | 10 (8-12) | 0.222 |
   PaO2/FiO2, mm Hg | 186 (142-269) | 123 (83-187) | 0.002 |
   SOFA cardiovascular score | 4 (4-4) | 4 (4-4) | 0.911 |
   Days on vasoactive medications | 5 (3-9) | 7 (4-9) | 0.340 |
   ICU LOS, days | 12 (8-22) | 12 (4-20) | 0.515 |
   Hospital LOS, days | 29 (17-49) | 17 (6-52) | 0.150 |
Comorbidities | Â | Â | Â |
   Coronary heart disease, n (%) | 6 (16) | 2 (8) | 0.373 |
   Hypertension, n (%) | 18 (49) | 10 (42) | 0.593 |
   Diabetes, n (%) | 12 (32) | 5 (21) | 0.324 |
   Chronic renal failure, n (%) | 6 (16) | 2 (8) | 0.373 |
Primary diagnosis of infection | Â | Â | Â |
   Pneumonia, n (%) | 18 (49) | 16 (67) | 0.166 |
   Bacteremia, n (%) | 5 (14) | 2 (8) | 0.535 |
   Peritonitis, n (%) | 5 (13) | 1 (4) | 0.231 |
   Others, n (%) | 9 (24) | 5 (21) | 0.751 |
Laboratory data | Â | Â | Â |
   Lactate, mM | 1.75 (1.30-2.88) | 2.00 (1.80-3.98) | 0.095 |
   WBC, ×109/L | 11.36 (7.18-19.99) | 12.07 (6.91-18.90) | 0.623 |
   Procalcitonin, ng/ml | 2.01 (0.59-7.40) | 1.50 (0.53-5.71) | 0.435 |
   cTnI, μg/L | 0.17 (0.06-1.14) | 0.15 (0.04-0.93) | 0.952 |
   CKMB, μg/L | 1.80 (0.60-3.83) | 1.65 (1.03-4.90) | 0.455 |
   NTproBNP, pg/ml | 4,072.00 (2,006.50-11,885.50) | 3,710.00 (1,361.50-10,618.25) | 0.693 |